SG Americas Securities’s Poseida Therapeutics, Inc. Common Stock PSTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-30,623
| Closed | -$294K | – | 3309 |
|
|
2024
Q4 | $294K | Buy |
30,623
+6,206
| +25% | +$59.6K | ﹤0.01% | 1599 |
|
|
2024
Q3 | $70K | Buy |
+24,417
| New | +$70K | ﹤0.01% | 2813 |
|
|
2024
Q2 | – | Sell |
-28,511
| Closed | -$91K | – | 2914 |
|
|
2024
Q1 | $91K | Sell |
28,511
-8,464
| -23% | -$27K | ﹤0.01% | 2299 |
|
|
2023
Q4 | $124K | Buy |
36,975
+2,049
| +6% | +$6.87K | ﹤0.01% | 2368 |
|
|
2023
Q3 | $83K | Buy |
34,926
+3,910
| +13% | +$9.29K | ﹤0.01% | 2568 |
|
|
2023
Q2 | $55K | Buy |
31,016
+7,056
| +29% | +$12.5K | ﹤0.01% | 1850 |
|
|
2023
Q1 | $74K | Buy |
+23,960
| New | +$74K | ﹤0.01% | 2731 |
|
|
2021
Q4 | – | Sell |
-21,323
| Closed | -$155K | – | 3427 |
|
|
2021
Q3 | $155K | Buy |
+21,323
| New | +$155K | ﹤0.01% | 3135 |
|